pixantrone has been researched along with Autoimmune Experimental Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antozzi, C; Baggi, F; Cordiglieri, C; Mantegazza, R; Marolda, R; Ruocco, C; Toscani, C | 1 |
| Antozzi, C; Baggi, F; Capobianco, R; Longhi, R; Mantegazza, R; Nava, S; Nessi, V; Pezzoni, G; Ubiali, F | 1 |
2 other study(ies) available for pixantrone and Autoimmune Experimental Myasthenia Gravis
| Article | Year |
|---|---|
Differential targeting of immune-cells by Pixantrone in experimental myasthenia gravis.
Topics: Animals; Cell Differentiation; Female; Isoquinolines; Lymphocytes; Myasthenia Gravis, Autoimmune, Experimental; Myeloid Progenitor Cells; Rats; Rats, Inbred Lew; Real-Time Polymerase Chain Reaction; Topoisomerase II Inhibitors | 2013 |
Pixantrone (BBR2778) reduces the severity of experimental autoimmune myasthenia gravis in Lewis rats.
Topics: Amino Acid Sequence; Animals; Cell Proliferation; Female; Immunodominant Epitopes; Immunosuppressive Agents; Isoquinolines; Lymphocyte Activation; Molecular Sequence Data; Myasthenia Gravis, Autoimmune, Experimental; Nicotinic Antagonists; Peptide Fragments; Rats; Rats, Inbred Lew; Receptors, Nicotinic; Severity of Illness Index; T-Lymphocytes; Torpedo | 2008 |